The story of the erectile dysfunction drug presents a intricate picture for investors. While the initial launch generated massive profits, the lapse of its patent get more info opened the door to generic alternatives, dramatically diminishing sales. This presents a specific challenge for pharmaceutical companies banking on related blockbuster produ

The history of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in income, its exclusivity period created a deluge of generic competition , significantly impacting its position . While certain businesses may try to capitalize on similar conditions , the curren